Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence
Mania, Hypomania, Cocaine Abuse
About this trial
This is an interventional treatment trial for Mania
Eligibility Criteria
Inclusion Criteria: Men and women ages 18-70 years History of mania or hypomania (bipolar I,II, not otherwise specified (NOS) or cyclothymic disorder or schizoaffective disorder/bipolar type) Early recovery for cocaine abuse/dependence (between 7 days and 12 weeks of enrollment). Any current mood state as indicated by structured diagnostic interview No psychotropic medication changes within 7 days prior to enrollment. English or Spanish speaking Exclusion Criteria: Pregnant/nursing woman Current or past citicoline therapy Active suicidal or homicidal ideation with plan and intent Dementia, mental retardation or other severe cognitive impairment Severe or life threatening medical condition
Sites / Locations
- The UT Southwestern Medical Center of Dallas
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Citicoline
Placebo
Citicoline is an over the counter supplement that may have neuroprotective properties and may have antidepressant effects.
Inactive ingredient matching the active medication in appearance